79 related articles for article (PubMed ID: 12703348)
21. Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma.
Riesenberg R; Weiler C; Spring O; Eder M; Buchner A; Popp T; Castro M; Kammerer R; Takikawa O; Hatz RA; Stief CG; Hofstetter A; Zimmermann W
Clin Cancer Res; 2007 Dec; 13(23):6993-7002. PubMed ID: 18056175
[TBL] [Abstract][Full Text] [Related]
22. p53 is an independent predictor of tumor recurrence and progression after nephrectomy in patients with localized renal cell carcinoma.
Shvarts O; Seligson D; Lam J; Shi T; Horvath S; Figlin R; Belldegrun A; Pantuck AJ
J Urol; 2005 Mar; 173(3):725-8. PubMed ID: 15711252
[TBL] [Abstract][Full Text] [Related]
23. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
[TBL] [Abstract][Full Text] [Related]
24. The expression of G250/mn/CA9 antigen by flow cytometry: its possible implication for detection of micrometastatic renal cancer cells.
Li G; Passebosc-Faure K; Lambert C; Gentil-Perret A; Blanc F; Oosterwijk E; Mosnier JF; Genin C; Tostain J
Clin Cancer Res; 2001 Jan; 7(1):89-92. PubMed ID: 11205923
[TBL] [Abstract][Full Text] [Related]
25. Altered expression of key cell cycle regulators in renal cell carcinoma associated with Xp11.2 translocation.
Barroca H; Castedo S; Vieira J; Teixeira M; Müller-Höcker J
Pathol Res Pract; 2009; 205(7):466-72. PubMed ID: 19246164
[TBL] [Abstract][Full Text] [Related]
26. Gene expression profiling of renal cell carcinoma: a DNA macroarray analysis.
Lovisolo JA; Casati B; Clerici L; Marafante E; Bono AV; Celato N; Salvadore M
BJU Int; 2006 Jul; 98(1):205-16. PubMed ID: 16831170
[TBL] [Abstract][Full Text] [Related]
27. CD70: a new tumor specific biomarker for renal cell carcinoma.
Junker K; Hindermann W; von Eggeling F; Diegmann J; Haessler K; Schubert J
J Urol; 2005 Jun; 173(6):2150-3. PubMed ID: 15879877
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.
Mizutani Y; Nakanishi H; Yamamoto K; Li YN; Matsubara H; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
J Clin Oncol; 2005 Jan; 23(3):448-54. PubMed ID: 15572731
[TBL] [Abstract][Full Text] [Related]
29. Expression of the secreted form of clusterin protein in renal cell carcinoma as a predictor of disease extension.
Kurahashi T; Muramaki M; Yamanaka K; Hara I; Miyake H
BJU Int; 2005 Oct; 96(6):895-9. PubMed ID: 16153225
[TBL] [Abstract][Full Text] [Related]
30. The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms.
Zhou M; Roma A; Magi-Galluzzi C
Clin Lab Med; 2005 Jun; 25(2):247-57. PubMed ID: 15848735
[TBL] [Abstract][Full Text] [Related]
31. Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy.
Klatte T; Seligson DB; LaRochelle J; Shuch B; Said JW; Riggs SB; Zomorodian N; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):894-900. PubMed ID: 19240241
[TBL] [Abstract][Full Text] [Related]
32. Renal cell carcinoma: current status and emerging therapies.
Nelson EC; Evans CP; Lara PN
Cancer Treat Rev; 2007 May; 33(3):299-313. PubMed ID: 17329029
[TBL] [Abstract][Full Text] [Related]
33. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
Meyer HA; Tölle A; Jung M; Fritzsche FR; Haendler B; Kristiansen I; Gaspert A; Johannsen M; Jung K; Kristiansen G
Eur Urol; 2009 Mar; 55(3):669-78. PubMed ID: 18450365
[TBL] [Abstract][Full Text] [Related]
34. CD98hc (SLC3A2), a novel marker in renal cell cancer.
Prager GW; Poettler M; Schmidinger M; Mazal PR; Susani M; Zielinski CC; Haitel A
Eur J Clin Invest; 2009 Apr; 39(4):304-10. PubMed ID: 19292886
[TBL] [Abstract][Full Text] [Related]
35. Paclitaxel/Taxol sensitivity in human renal cell carcinoma is not determined by the p53 status.
Reinecke P; Kalinski T; Mahotka C; Schmitz M; Déjosez M; Gabbert HE; Gerharz CD
Cancer Lett; 2005 May; 222(2):165-71. PubMed ID: 15863265
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of common preoperative laboratory variables in clear cell renal cell carcinoma.
Lee SE; Byun SS; Han JH; Han BK; Hong SK
BJU Int; 2006 Dec; 98(6):1228-32. PubMed ID: 17034508
[TBL] [Abstract][Full Text] [Related]
37. Understanding the molecular genetics of renal cell neoplasia: implications for diagnosis, prognosis and therapy.
Cheng L; Williamson SR; Zhang S; Maclennan GT; Montironi R; Lopez-Beltran A
Expert Rev Anticancer Ther; 2010 Jun; 10(6):843-64. PubMed ID: 20553210
[TBL] [Abstract][Full Text] [Related]
38. MN/CA9 gene expression as a potential biomarker in renal cell carcinoma.
Murakami Y; Kanda K; Tsuji M; Kanayama H; Kagawa S
BJU Int; 1999 May; 83(7):743-7. PubMed ID: 10368188
[TBL] [Abstract][Full Text] [Related]
39. Circulating large extracellular vesicles carrying CA9 in the diagnosis and prognosis of clear-cell renal cell carcinoma.
Vergori L; Martinez MC; Bigot P
Clin Transl Med; 2021 Mar; 11(3):e358. PubMed ID: 33783991
[No Abstract] [Full Text] [Related]
40. Biochemical and molecular markers in renal cell carcinoma: an update and future prospects.
Kashyap MK; Kumar A; Emelianenko N; Kashyap A; Kaushik R; Huang R; Khullar M; Sharma SK; Singh SK; Bhargave AK; Upadhyaya SK
Biomarkers; 2005; 10(4):258-94. PubMed ID: 16191485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
